Status:
COMPLETED
Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.
Lead Sponsor:
Bayer
Conditions:
Neoplastic CNS Lesions
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Study to compare of two contrast agents in imaging brain lesions.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Known neoplastic CNS lesions
Exclusion
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT00764387
Start Date
March 1 2008
End Date
May 1 2009
Last Update
December 5 2014
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Andria, Bari, Italy, 70031
2
Catania, Italy, 95126
3
Chieti, Italy, 66013
4
Messina, Italy, 98122